Safety, tolerability, and pharmacokinetic evaluation of single and multiple doses of the dipeptidyl peptidase 1 (dpp1) inhibitor brensocatib in healthy japanese and white adults

Authors
Category Primary study
JournalAmerican Journal of Respiratory and Critical Care Medicine
Year 2021
This article has no abstract
Epistemonikos ID: bfb3d531d8cc859d5556c0674bdcbab7a360396f
First added on: Feb 12, 2025